OBJECTIVE: To perform an extensive search for genomic rearrangements by microarray-based comparative genomic hybridization in patients with epilepsy. DESIGN: Prospective cohort study. SETTING: Epilepsy centers in Italy. PATIENTS: Two hundred seventy-nine patients with unexplained epilepsy, 265 individuals with nonsyndromic mental retardation but no epilepsy, and 246 healthy control subjects were screened by microarray-based comparative genomic hybridization. MAIN OUTCOME MEASURES: Identification of copy number variations (CNVs) and gene enrichment. RESULTS: Rare CNVs occurred in 26 patients (9.3%) and 16 healthy control subjects (6.5%) (P = .26). The CNVs identified in patients were larger (P = .03) and showed higher gene content (P = .02) than those in control subjects. The CNVs larger than 1 megabase (P = .002) and including more than 10 genes (P = .005) occurred more frequently in patients than in control subjects. Nine patients (34.6%) among those harboring rare CNVs showed rearrangements associated with emerging microdeletion or microduplication syndromes. Mental retardation and neuropsychiatric features were associated with rare CNVs (P = .004), whereas epilepsy type was not. The CNV rate in patients with epilepsy and mental retardation or neuropsychiatric features is not different from that observed in patients with mental retardation only. Moreover, significant enrichment of genes involved in ion transport was observed within CNVs identified in patients with epilepsy. CONCLUSIONS: Patients with epilepsy show a significantly increased burden of large, rare, gene-rich CNVs, particularly when associated with mental retardation and neuropsychiatric features. The limited overlap between CNVs observed in the epilepsy group and those observed in the group with mental retardation only as well as the involvement of specific (ion channel) genes indicate a specific association between the identified CNVs and epilepsy. Screening for CNVs should be performed for diagnostic purposes preferentially in patients with epilepsy and mental retardation or neuropsychiatric features.
OBJECTIVE: To perform an extensive search for genomic rearrangements by microarray-based comparative genomic hybridization in patients with epilepsy. DESIGN: Prospective cohort study. SETTING:Epilepsy centers in Italy. PATIENTS: Two hundred seventy-nine patients with unexplained epilepsy, 265 individuals with nonsyndromic mental retardation but no epilepsy, and 246 healthy control subjects were screened by microarray-based comparative genomic hybridization. MAIN OUTCOME MEASURES: Identification of copy number variations (CNVs) and gene enrichment. RESULTS: Rare CNVs occurred in 26 patients (9.3%) and 16 healthy control subjects (6.5%) (P = .26). The CNVs identified in patients were larger (P = .03) and showed higher gene content (P = .02) than those in control subjects. The CNVs larger than 1 megabase (P = .002) and including more than 10 genes (P = .005) occurred more frequently in patients than in control subjects. Nine patients (34.6%) among those harboring rare CNVs showed rearrangements associated with emerging microdeletion or microduplication syndromes. Mental retardation and neuropsychiatric features were associated with rare CNVs (P = .004), whereas epilepsy type was not. The CNV rate in patients with epilepsy and mental retardation or neuropsychiatric features is not different from that observed in patients with mental retardation only. Moreover, significant enrichment of genes involved in ion transport was observed within CNVs identified in patients with epilepsy. CONCLUSIONS:Patients with epilepsy show a significantly increased burden of large, rare, gene-rich CNVs, particularly when associated with mental retardation and neuropsychiatric features. The limited overlap between CNVs observed in the epilepsy group and those observed in the group with mental retardation only as well as the involvement of specific (ion channel) genes indicate a specific association between the identified CNVs and epilepsy. Screening for CNVs should be performed for diagnostic purposes preferentially in patients with epilepsy and mental retardation or neuropsychiatric features.
Authors: Gabrielle S Vianna; Mariana L Freitas; Valdirene T de Oliveira; Rafaella X Pietra; Michele da S Gonçalves; Patrícia P O Rocha; Rejane A C Monteiro; Luana C A Ferreira; Rosana R Xavier; Andréia M Carvalho; Patrícia R de M Lima; Maria Augusta N P Monteiro; Elvis C Mateo; Juliana G Giannetti; Giovana da C César; Joziele de S Lima; Paula F V Medeiros; Fernanda S Jehee Journal: Mol Syndromol Date: 2016-11-01
Authors: Felippe Borlot; Brigid M Regan; Anne S Bassett; D James Stavropoulos; Danielle M Andrade Journal: JAMA Neurol Date: 2017-11-01 Impact factor: 18.302
Authors: Heather Olson; Yiping Shen; Jennifer Avallone; Beth R Sheidley; Rebecca Pinsky; Ann M Bergin; Gerard T Berry; Frank H Duffy; Yaman Eksioglu; David J Harris; Fuki M Hisama; Eugenia Ho; Mira Irons; Christina M Jacobsen; Philip James; Sanjeev Kothare; Omar Khwaja; Jonathan Lipton; Tobias Loddenkemper; Jennifer Markowitz; Kiran Maski; J Thomas Megerian; Edward Neilan; Peter C Raffalli; Michael Robbins; Amy Roberts; Eugene Roe; Caitlin Rollins; Mustafa Sahin; Dean Sarco; Alison Schonwald; Sharon E Smith; Janet Soul; Joan M Stoler; Masanori Takeoka; Wen-Han Tan; Alcy R Torres; Peter Tsai; David K Urion; Laura Weissman; Robert Wolff; Bai-Lin Wu; David T Miller; Annapurna Poduri Journal: Ann Neurol Date: 2014-06-13 Impact factor: 10.422
Authors: Norman Delanty; Gianpiero L Cavalleri; Katherine A Benson; Maire White; Nicholas M Allen; Susan Byrne; Robert Carton; Elizabeth Comerford; Daniel Costello; Colin Doherty; Brendan Dunleavey; Hany El-Naggar; Nisha Gangadharan; Sinéad Heavin; Hugh Kearney; Nicholas J Lench; John Lynch; Mark McCormack; Mary O' Regan; Karl Podesta; Kevin Power; Anthony S Rogers; Charles A Steward; Brian Sweeney; David Webb; Mary Fitzsimons; Marie Greally Journal: Eur J Hum Genet Date: 2020-04-01 Impact factor: 4.246
Authors: Krishna Chinthapalli; Emanuele Bartolini; Jan Novy; Michael Suttie; Carla Marini; Melania Falchi; Zoe Fox; Lisa M S Clayton; Josemir W Sander; Renzo Guerrini; Chantal Depondt; Raoul Hennekam; Peter Hammond; Sanjay M Sisodiya Journal: Brain Date: 2012-09-13 Impact factor: 13.501
Authors: Danielle P Moreira; Karina Griesi-Oliveira; Ana L Bossolani-Martins; Naila C V Lourenço; Vanessa N O Takahashi; Kátia M da Rocha; Eloisa S Moreira; Estevão Vadasz; Joanna Goes Castro Meira; Debora Bertola; Eoghan O'Halloran; Tiago R Magalhães; Agnes C Fett-Conte; Maria Rita Passos-Bueno Journal: PLoS One Date: 2014-09-25 Impact factor: 3.240
Authors: Andrew E Fry; Elliott Rees; Rose Thompson; Kiran Mantripragada; Penny Blake; Glyn Jones; Sian Morgan; Sian Jose; Hood Mugalaasi; Hayley Archer; Emma McCann; Angus Clarke; Clare Taylor; Sally Davies; Frances Gibbon; Johann Te Water Naude; Louise Hartley; Gareth Thomas; Catharine White; Jaya Natarajan; Rhys H Thomas; Cheney Drew; Seo-Kyung Chung; Mark I Rees; Peter Holmans; Michael J Owen; George Kirov; Daniela T Pilz; Michael P Kerr Journal: BMC Med Genet Date: 2016-04-26 Impact factor: 2.103